Cargando…
miRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer
Triple negative breast cancer (TNBC) is characterised by the lack of receptors for estrogen (ER), progesterone (PR), and human epidermal growth factor 2 (HER2). Since it cannot be treated by current endocrine therapies which target these receptors and due to its aggressive nature, it has one of the...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4691037/ https://www.ncbi.nlm.nih.gov/pubmed/26633365 http://dx.doi.org/10.3390/ijms161226090 |